Compare iShares China Large-Cap ETF (FXI) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares China Large-Cap ETF vs Marsh & McLennan Companies, Inc. — how do they compare? iShares China Large-Cap ETF trades at $34.55, while Marsh & McLennan Companies, Inc. trades at $180.97 (market cap $84.90B). The key difference: Marsh & McLennan Companies, Inc. pays a 2.25% dividend while iShares China Large-Cap ETF pays none, and Marsh & McLennan Companies, Inc. is trading nearer its 52-week high, iShares China Large-Cap ETF nearer its low. Which is the better fit depends on your goals.
| FXI | MRSH | |
|---|---|---|
52-Week High | $41.75 | $212.28 |
52-Week Low | $31.59 | $157.32 |
Market Cap | — | $84.90B |
Sector | — | Financials |
Enterprise Value | — | $105.74B |
Dividend Yield | — | 2.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FXI is currently trading at $34.545, up 2.29% with strong technical momentum indicated by bullish moving averages and ADX signals. The ETF benefits from China's accelerating AI and manufacturing sectors, with recent news highlighting a $295 billion AI infrastructure plan and robust export growth. However, RSI readings above 89 suggest the ETF is significantly overbought near-term.
The outlook remains positive given China's strategic investments in technology and manufacturing, though investors face risks from US-China trade tensions and potential profit-taking after recent gains. Wall Street sentiment is cautiously optimistic as institutional flows respond to China's economic initiatives.
Marsh (MRSH) trades at $181.18, up 1.76% today, near its R3 resistance of $181. The stock shows a bullish technical signal, with recent earnings beats and a 10% dividend increase to $0.99 per share. Revenue grew to $26.98B in 2025, with a net income margin of 14.26%, while the P/E ratio stands at 22.03. Analyst consensus is a buy rating from 11 of 33 analysts, with a price target of $203.67.
The outlook is positive with sustained organic growth and shareholder returns, but risks include rising operating expenses and a premium valuation. Earnings growth and AI initiatives are key catalysts, though softer insurance pricing and debt levels warrant monitoring for potential volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares China Large-Cap ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index designed to measure the performance of the largest companies in the Chinese equity market that trade on the Stock Exchange of Hong Kong and are available to international investors. The fund is non-diversified.
Read more on FXI →About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →
